We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immunodiagnostic Systems Holdings Plc | LSE:IDH | London | Ordinary Share | GB00B01YZ052 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 378.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDH
RNS Number : 3125V
Immunodiagnostic Systems Hldgs PLC
01 November 2017
1 November 2017
Immunodiagnostic Systems Holdings plc (the "Company")
Additional Listing
Application has today been made to AIM for admission of 35,000 new Ordinary Shares of 2 pence each in the Company ("Shares"). These Shares, which will rank pari passu in all respects with the existing shares in issue, are being issued pursuant to the exercise of options under the Company's Unapproved Share Option Scheme.
Admission is expected to become effective on 7 November 2017. Following admission to trading of the Shares, the Company will have 29,450,175 Ordinary Shares of 2 pence each in issue of which 12,447 are held as treasury shares leaving a balance of 29,437,728 ordinary shares with voting rights.
For further information:
Immunodiagnostic Systems Tel: +44 (0) 191 519 Holdings plc 0660 Paul Martin, Group Finance Director Peel Hunt LLP Tel: +44 (0) 20 7418 8900 James Steel Oliver Jackson
This information is provided by RNS
The company news service from the London Stock Exchange
END
ALSUGGRPGUPMGQG
(END) Dow Jones Newswires
November 01, 2017 12:29 ET (16:29 GMT)
1 Year Immunodiagnostic Systems Chart |
1 Month Immunodiagnostic Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions